# Perrigo Announces Quarterly Dividend
Canonical URL: https://biopharmsignal.com/news/PRGO/perrigo-announces-quarterly-dividend
Ticker: PRGO
Company: Perrigo Company PLC
Source: PRGO
Published: 2026-04-29 12:56 EST
Original Source URL: https://investor.perrigo.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-30 20:25 EST — [Perrigo Announces Appointment of Two New Independent Directors to Board](https://biopharmsignal.com/news/PRGO/perrigo-announces-appointment-of-two-new-independent-directors-to-board-47cee7b5) — Source: Perrigo Company PLC
- 2026-06-08 20:31 EST — [Perrigo Announces Leadership Transition](https://biopharmsignal.com/news/PRGO/perrigo-announces-leadership-transition-fef2604a) — Source: Perrigo Company PLC
- 2026-05-26 12:30 EST — [Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-oppenheimer-26th-annual-consumer-growth-and-e-commerce-conference) — Source: Perrigo Company PLC
- 2026-05-06 10:30 EST — [Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations](https://biopharmsignal.com/news/PRGO/perrigo-reports-first-quarter-2026-financial-results-from-continuing-operations) — Source: PRGO
- 2026-04-30 20:30 EST — [Perrigo Completes Divestiture of Dermacosmetics Business](https://biopharmsignal.com/news/PRGO/perrigo-completes-divestiture-of-dermacosmetics-business) — Source: PRGO
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)